Home › Funds › GLENVIEW CAPITAL MANAGEMENT, LLC › AZN
GLENVIEW CAPITAL MANAGEMENT, LLC position in AZN
ASTRAZENECA PLC · Health Care
GLENVIEW CAPITAL MANAGEMENT, LLC reported holding 184,279 shares of AZN (ASTRAZENECA PLC) in its Q2 2026 13F filing — a position valued at US$34.9M, representing 0.67% of its reported portfolio and ranking #32 among its reported holdings. GLENVIEW CAPITAL MANAGEMENT, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GLENVIEW CAPITAL MANAGEMENT, LLC's AZN position evolved
GLENVIEW CAPITAL MANAGEMENT, LLC first disclosed a stake in AZN in Q2 2026 at 184,279 shares (US$34.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 184.28K | $34.94M | New |
About AZN and 13F data
AZN (ASTRAZENECA PLC) is a Health Care company. 71 other funds we track also report a position in AZN — the largest reported positions include Evelyn Partners Group Ltd (US$41.52B), Banque Cantonale Vaudoise (US$11.31B), INVESTOR AB (US$9.78B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AZN
- Evelyn Partners Group Ltd 2.24M sh · $41.52B · Q2 2026
- Banque Cantonale Vaudoise 60.46K sh · $11.31B · Q2 2026
- INVESTOR AB 51.59M sh · $9.78B · Q2 2026
- Capital International Investors 34.58M sh · $6.49B · Q2 2026
- Norges Bank Investment Management 33.86M sh · $6.33B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Capital World Investors 30.08M sh · $5.63B · Q2 2026
- Wellington Management Group 28.54M sh · $5.36B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 28.54M sh · $5.36B · Q2 2026
- Legal & General Investment Management America 25.75M sh · $4.82B · Q2 2026
- VANGUARD ASSET MANAGEMENT, Ltd 18.71M sh · $3.49B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 18.10M sh · $3.43B · Q2 2026
More on GLENVIEW CAPITAL MANAGEMENT, LLC
FAQ
How long has GLENVIEW CAPITAL MANAGEMENT, LLC held AZN?
GLENVIEW CAPITAL MANAGEMENT, LLC has disclosed AZN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is GLENVIEW CAPITAL MANAGEMENT, LLC's current position in AZN?
As of Q2 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 184.28K shares of AZN (ASTRAZENECA PLC), valued at $34.94M, representing 0.67% of its reported portfolio and ranking #32.
Has GLENVIEW CAPITAL MANAGEMENT, LLC been buying or selling AZN?
In the latest 13F filing (Q2 2026), GLENVIEW CAPITAL MANAGEMENT, LLC newly opened its position in AZN.
Which other funds hold AZN?
Other major institutional holders of AZN include Evelyn Partners Group Ltd, Banque Cantonale Vaudoise, INVESTOR AB, among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.